Advertisement

Topics

Companies Related to "Takeda TiGenix Announce Publication Lancet Week Results Phase" [Most Relevant Company Matches] [Advanced Search Results] RSS

17:45 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Takeda TiGenix Announce Publication Lancet Week Results Phase" found in our extensive corporate database of over 50,000 company records.

Showing "Takeda TiGenix Announce Publication Lancet Week Results Phase" Companies 1–25 of 2,400+

Extremely Relevant

The Lancet Customer Services, Elsevier Ltd,

2005 When Thomas Wakley founded The Lancet in 1823, he announced "A lancet can be an arched window to let in the light or it can be a sharp surgical instrument to cut out the dross and I intend to use it in both senses". This philosophy remains at the heart of the journal today. The Lancet first appeared on Oct 5, 1823. From the beginning, Wakley's aim was to entertain, instruct, and reform. Inst...


Relevant

TiGenix NV

TiGenix NV (NYSE Euronext: TIG) is a leading European cell therapy company with a commercial product and an advanced clinical stage pipeline of adult stem cell programs. The company’s lead product, ChondroCelect®, for cartilage repair in the knee, is the only approved cell-based product in Europe, and is currently being launched in different European countries. TiGenix’s stem c...

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antibody IND Engine for human antibody therapeutics for the treatment of cancer, inflammation and metabolic diseases. TSF supports Takeda's therapeutic antibody initiative in close collaboration with Take...


Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the largest pharmaceutical company in Japan. Takeda Pharmaceuticals International, Inc. is the hub for R&D excellence and the commercial activities in Americas and Europe as well as other s...

Takeda San Francisco Inc.

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and development of antibodies, enhancement of antibody activity and antibody-manufacturing in close collaboration with Takeda's other R&D organizations. Additional information about Takeda San Francisco i...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion for improving the lives of cancer patients. Takeda Oncology was formerly known as Millennium: The Takeda Oncology Company. Additional information about Takeda Oncology is availabl...

Takeda Pharmaceuticals Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is avail...

Envoy Therapeutics Inc. and Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is ava...

Takeda Pharmaceuticals U.S.A., Inc. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology, and cardiovascular treatments and seek ...

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda...

Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc.

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda...

Takeda Pharmaceuticals U.S.A. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology and cardiovascular disease treatments and seek to...

Takeda Pharmaceutical North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a p...

Mended Hearts and Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a p...

Takeda Global Research & Development Center, Inc., U.S.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a p...

Thomson BioWorld

Medical Device Daily is the newspaper of record for the high-tech medical technology industry and is relied on by thousands of industry insiders every business morning. This business-focused intelligence service is the flagship publication of Thomson BioWorld's med-tech group, the publishers, also, of Biomedical Business & Technology, Cardiovascular Device Update, Diagnostics & Imaging Week, Medic...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

Takeda San Diego

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. Multiple drug candidates discovered at TSD are currently in clinical trials including SYR322, a pot...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May, 2008. The Company’s research, developmen...

Takeda Global Research & Development Center, Inc.

Takeda Global Research & Development Center, Inc. (TGRD) is a company focused on becoming an integrated, global, world-class pharmaceutical development organization with the ability to rapidly bring superior products to market to improve patient health and enhance the practice of medicine. Established in January 2004, TGRD integrates the clinical development activity of the Takeda Pharmaceutical N...

San Fernando Valley Business Journal

The San Fernando Valley Business Journal is the best source for local business news. The award-winning publication prints top company lists, breaking stories, big deals, business advice, executive profiles ... news and information that helps you understand and succeed in your local business environment. Use this site to subscribe to the print edition and read this week's issue online. Or search th...

CE Week

CE Week, a trade-only event, is the consumer electronics (CE) industry’s weeklong, citywide event in New York City. The official mid-year conference and new technology showcase includes the event headquarters, CE Week Line Shows and Exhibits, which is the site of CE Week’s largest exhibition hall and conference program. CE Week is organized in as...

Takeda Pharmaceuticals North America

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcare. With a foundation built on the tremendous success of ACTOS® (pioglitazone HCl) as well as a robust, early-stage pipeline, TPNA is poised to realize its vision of becoming a world class pharmaceuti...

Ysios Capital

Ysios Capital is an independent venture capital firm providing private equity financing to early through late-stage human healthcare and biotechnology companies with special focus on pharmaceuticals, diagnostics and medical devices. Ysios launched its first 69 million Euro fund Ysios BioFund I in 2008. Ysios has invested in 10 companies, and has successful...

Lancet Software


More From BioPortfolio on "Takeda TiGenix Announce Publication Lancet Week Results Phase"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks